On January 31, 1995, the Alpha-1 Foundation was incorporated as a not-for-profit organization by its three co-founders, John W. Walsh, Sandy Lindsey, and Susan Stanley.
Their incredible vision and passion to create a better future for Alphas worldwide still drive the mission of the Foundation, 25 years later.
2020 Impact Report
Alpha-1 Foundation’s Scientific Director Mark Brantly, M.D. outlines all of the contributions and progress the Foundation has made in the last 25 years in search for a cure. Read the full presentation below!
The Alpha-1 Foundation, founded in 1995, is committed to finding a cure for Alpha-1 Antitrypsin Deficiency (Alpha-1) and to improving the lives of people affected by the condition worldwide.
The Foundation has invested over $76 million to support Alpha-1 research and programs at 116 institutions in North America, Europe, the Middle East, and Australia.